Unspecified Sleep-Wake Disorder, as categorized in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), represents a category of sleep disorders that do not fit neatly into other specific sleep disorder categories. This diagnostic classification is utilized when a person exhibits symptoms or behaviors associated with sleep disturbances that cause significant distress or impairment in social, occupational, or other important areas of functioning. Still, these symptoms do not align precisely with the criteria for any specific sleep disorder outlined in the DSM-5-TR (American Psychiatric Association [APA], 2023).

Individuals with Unspecified Sleep-Wake Disorder may present with a variety of symptoms, which can include difficulty initiating or maintaining sleep (insomnia), excessive sleepiness (hypersomnia), or a sleep schedule that is out of alignment with the typical day-night cycle (circadian rhythm disorder). They may also experience abnormal events or behaviors during sleep, such as sleepwalking or nightmares, which are not sufficiently frequent or severe to meet the criteria for other sleep disorders like sleepwalking disorder or nightmare disorder. The critical aspect is that these symptoms are causing significant distress or impairment but do not conform to the specific criteria of other defined sleep disorders.

This category is beneficial for clinicians when the information needed to make a more specific diagnosis is unavailable, such as in emergency room settings, or when the symptoms are complex and multifaceted, thus not fitting into a single, specific sleep disorder category. The use of "Unspecified" diagnoses like this one allows for appropriate recognition and treatment of the disorder without forcing a clinician to assign a more specific diagnosis that may not accurately reflect the patient's condition.

In terms of supporting evidence, research in the field of sleep disorders often highlights the importance of considering a wide range of potential symptoms and causes when diagnosing and treating sleep-related issues. This approach is consistent with the rationale behind the Unspecified Sleep-Wake Disorder category in the DSM-5-TR.

Diagnostic Criteria

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), categorizes Unspecified Sleep-Wake Disorder under the broader umbrella of sleep-wake disorders. This category is used when a patient's sleep-related symptoms are significant enough to warrant clinical attention. Still, the specific criteria for one of the other sleep-wake disorders are not met. The diagnostic criteria for Unspecified Sleep-Wake Disorder are intentionally broad and less specific, allowing clinicians the flexibility to diagnose sleep disorders that do not align neatly with other predefined categories (APA, 2023).

In clinical practice, a diagnosis of Unspecified Sleep-Wake Disorder is typically considered when a patient presents with sleep disturbances that cause significant distress or impairment in critical areas of functioning such as social, occupational, or other daily activities. These disturbances could manifest as difficulties in initiating or maintaining sleep, excessive sleepiness, or irregular sleep-wake patterns that do not fit the criteria for more specific disorders like insomnia, narcolepsy, or circadian rhythm sleep-wake disorders.

The rationale for including such a category in the DSM-5-TR is supported by research in sleep medicine, which recognizes the complexity and diversity of sleep disorders. For instance, a study by Ohayon and Roth (2003) highlights the prevalence of sleep disorders and the need for a comprehensive approach to diagnosis, acknowledging that many patients exhibit symptoms that span multiple sleep disorder categories. Similarly, a review by Baglioni et al. (2014) on insomnia and its comorbidities suggests that sleep disorders often intersect with other mental and physical health issues, further complicating diagnosis and treatment.

Unspecified Sleep-Wake Disorder serves as a diagnostic placeholder, especially useful in situations where complete information is unavailable or when a patient's symptoms are in flux. This category ensures that patients receive appropriate recognition and treatment for their sleep-related issues, even when their symptoms do not align perfectly with more defined disorders.

In the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5-TR), the category of Unspecified Sleep-Wake Disorder does not have specific specifiers associated with it. This is primarily because this category is a catch-all diagnosis used when a patient's sleep-related symptoms do not neatly fit into the other defined sleep-wake disorders.

The purpose of Unspecified Sleep-Wake Disorder is to provide a diagnostic option for clinicians when the exact nature of the sleep disorder is unclear, when there is insufficient information to make a more specific diagnosis, or when the symptoms do not meet the full criteria for any other sleep-wake disorder. Because of its broad nature, it lacks specific subtypes or specifiers commonly found in other DSM-5-TR categories.

However, clinicians may note relevant features of the patient's presentation in their diagnostic assessment. These may include the predominant symptoms (such as insomnia, hypersomnia, circadian rhythm issues, or parasomnias), the severity of the disorder, the duration of the symptoms, and any notable factors related to the onset or exacerbation of the sleep issues.

For more detailed or specific diagnosis and treatment, further assessment and information gathering are typically necessary to identify the exact nature of the sleep disorder. Depending on the case, this might involve sleep logs, medical evaluations, psychological assessments, or sleep studies.

The Impacts

Unspecified Sleep-Wake Disorder, as classified in the DSM-5-TR, can have a broad range of impacts on an individual's life, mirroring the effects seen in other, more specific sleep disorders. The implications of sleep disturbances are well-documented in the literature and can be extensive, affecting physical, psychological, and social aspects of life.

Physically, chronic sleep disturbances have been linked to a variety of health issues. Research has shown a connection between poor sleep quality and increased risk of cardiovascular diseases, obesity, diabetes, and weakened immune function (Knutson, 2007; Besedovsky et al., 2012). In their study, Knutson et al. found that reduced sleep duration and quality were associated with an increased prevalence of cardiovascular diseases and diabetes.

Psychologically, individuals with Unspecified Sleep-Wake Disorder may experience symptoms similar to those with other sleep disorders, including increased levels of stress, anxiety, and depression. Baglioni et al. (2011) conducted a review that highlighted the bidirectional relationship between insomnia and depression, suggesting that sleep disturbances can both contribute to and exacerbate mental health issues.

Socially and occupationally, sleep disorders can impair cognitive function, concentration, and overall daytime performance. A study by Lim and Dinges (2010) demonstrated that sleep deprivation adversely affects cognitive performance, particularly attention and working memory, which can have significant implications for daily functioning and work performance.

The impact of Unspecified Sleep-Wake Disorder is compounded by the fact that the disorder's unspecified nature might delay the identification of the underlying cause of the sleep disturbance, potentially prolonging these adverse outcomes.

The Etiology (Origins and Causes)

The etiology of Unspecified Sleep-Wake Disorder in the DSM-5-TR is inherently complex due to the disorder's nature as a catch-all category for sleep disturbances that do not fit into the specific criteria of other sleep disorders. However, understanding the origins and causes of general sleep disturbances can provide insight into the potential etiological factors for this disorder.

Sleep disorders, in general, can arise from various biological, psychological, and environmental factors. Biologically, genetic predispositions to certain sleep disorders have been identified. A study by Barclay and Gregory (2013) highlighted the genetic underpinnings of various sleep disorders, indicating that genetic factors can play a significant role in their development.

Psychological factors, including stress and mental health disorders such as anxiety and depression, are also known contributors to sleep disturbances. A review by Baglioni et al. (2011) examined the relationship between insomnia and psychological stress, suggesting that heightened stress and maladaptive coping strategies can lead to the development of sleep problems.

Environmental factors, including lifestyle choices and exposure to light, particularly blue light from screens, can also disrupt sleep patterns. A research by Chang et al. (2015) demonstrated that evening exposure to blue light-emitting screens can negatively impact sleep quality by affecting melatonin production, thus disrupting the circadian rhythm.

In some cases, the underlying cause of sleep disturbances might be related to other medical conditions, such as chronic pain or respiratory disorders, which can disrupt normal sleep patterns. A study by Smith et al. (2007) explored the relationship between chronic pain and sleep disturbances, finding that pain can significantly disrupt sleep, leading to a cycle of pain and poor sleep quality.

Given the unspecified nature of Unspecified Sleep-Wake Disorder, these etiological factors can vary widely among individuals diagnosed with this condition. The disorder may encompass a mix of these factors, making it a complex and multifaceted condition to understand and treat.

Comorbidities

Comorbidities associated with Unspecified Sleep-Wake Disorder, as with other sleep disorders, can be quite varied, reflecting the complex interactions between sleep and overall health. Research in sleep medicine has consistently shown that sleep disturbances can co-occur with a range of physical and mental health conditions.

One of the most commonly observed comorbidities with sleep disorders is mental health issues, particularly anxiety and depression. A study by Ford and Kamerow (1989) established a strong link between chronic insomnia and the development of depression. Their research found that individuals with insomnia had a higher risk of subsequently developing depression. Similarly, anxiety disorders are often found to coexist with sleep disturbances. Taylor et al. (2005) conducted a study that showed a significant association between anxiety disorders and various sleep abnormalities.

In terms of physical health, sleep disorders are frequently associated with cardiovascular diseases. A review by Somers et al. (2008) discussed how disrupted sleep, especially disorders like sleep apnea, is linked to an increased risk of hypertension, heart disease, and stroke. Moreover, sleep disturbances have been connected to metabolic issues like obesity and diabetes. A study by Tasali, Leproult, and Spiegel (2008) explored the impact of sleep deprivation on glucose metabolism, illustrating how poor sleep can contribute to developing type 2 diabetes and obesity.

Chronic pain is another common comorbidity with sleep disorders. Smith and Haythornthwaite (2004) examined the bidirectional relationship between chronic pain and sleep disturbances. Their findings indicated that not only can chronic pain lead to sleep disturbances, but poor sleep can also exacerbate the perception of pain.

Given the unspecified nature of Unspecified Sleep-Wake Disorder, these comorbidities may not apply uniformly to all individuals with the disorder. However, they highlight the potential complexities in diagnosing and treating this condition.

Risk Factors

The risk factors for Unspecified Sleep-Wake Disorder, as identified in sleep research, often overlap with those for other sleep disorders due to the broad and encompassing nature of this category in the DSM-5-TR. These risk factors include a mix of lifestyle, environmental, physiological, and psychological elements.

Lifestyle factors play a significant role in sleep health. Habits such as irregular sleep schedules, excessive caffeine or alcohol consumption, and inadequate physical activity have been linked to sleep disturbances. A study by Watson et al. (2017) explored lifestyle factors and their impact on sleep, finding that those with irregular sleep patterns, poor diet, and lack of regular exercise had a higher prevalence of sleep disorders.

Environmental factors, including exposure to light, especially blue light from electronic devices before bedtime, can disrupt the body's natural circadian rhythm. Chang et al. (2015) demonstrated that using light-emitting screens before bed can significantly impact sleep quality by suppressing melatonin production.

Physiological factors, including age and gender, also influence sleep. Older adults are often more susceptible to sleep disorders, as found in a study by Foley et al. (1999), which reported an increased prevalence of sleep disturbances among older adults. Additionally, gender differences in sleep patterns and disorders have been noted, with women being more prone to insomnia, as indicated by research from Zhang and Wing (2006).

Psychological stress and mental health disorders such as anxiety and depression are also key risk factors. A longitudinal study by Baglioni et al. (2011) highlighted the strong association between insomnia, a common sleep disorder, and psychological stress and mood disorders.

It is important to note that these risk factors can interact in complex ways, and the presence of one or more does not necessarily cause Unspecified Sleep-Wake Disorder but instead increases the likelihood of its occurrence.

Case Study

Background: Felicia, a 38-year-old graphic designer, presented to the clinic with complaints of chronic sleep disturbances that have persisted for approximately six months. She reported difficulties with both falling asleep and staying asleep, as well as episodes of waking up earlier than intended with an inability to return to sleep. Felicia also mentioned experiencing intermittent periods of excessive daytime sleepiness and fatigue.

Clinical Presentation: Felicia described her sleep problems as having a significant impact on her daily functioning, particularly noting decreased concentration and productivity at work, increased irritability, and a general sense of feeling unwell. She denied any significant changes in her life circumstances, medication use, or substance use that might account for these sleep disturbances.

Medical and Psychiatric History: Felicia's medical history was unremarkable, with no chronic illnesses or ongoing medication use. She had no prior history of mental health issues, and her family history was adverse for sleep disorders. Felicia denied the use of alcohol, tobacco, or recreational drugs.

Assessment and Diagnosis: Given the lack of specific symptoms aligning with a particular sleep disorder such as insomnia, sleep apnea, or narcolepsy, and after ruling out other potential medical or psychiatric causes, Felicia was diagnosed with Unspecified Sleep-Wake Disorder as per DSM-5-TR criteria. This diagnosis was made due to her significant sleep-related complaints, which did not meet the full criteria for a more specific sleep disorder.

Management and Treatment: Felicia was advised to maintain a regular sleep schedule and practice good sleep hygiene, including limiting screen time before bed and creating a comfortable sleep environment. Cognitive-behavioral therapy for insomnia (CBT-I) was recommended to address maladaptive thoughts and behaviors related to sleep. A follow-up appointment was also scheduled to reassess her symptoms and consider further investigations or referrals if necessary.

Outcome: At the follow-up visit six weeks later, Felicia reported some improvement in her sleep quality. She found the sleep hygiene techniques particularly helpful and was engaging in CBT-I. However, she still experienced occasional nights of disrupted sleep. The treatment plan was to continue with CBT-I and reassess in another six weeks.

Discussion: This case illustrates the complexity of diagnosing and managing sleep disorders when they do not fit neatly into specific categories. Unspecified Sleep-Wake Disorder is a valid diagnostic category in such cases, allowing for recognizing and treating significant sleep disturbances even when they elude more precise classification. Non-pharmacological interventions, such as sleep hygiene and CBT-I, are underscored in managing such cases.

Recent Psychology Research Findings

The research surrounding Unspecified Sleep-Wake Disorder, as categorized in the DSM-5-TR, is limited due to the broad and nonspecific nature of this diagnostic category. However, studies that explore the broader impacts and treatment approaches for various sleep disorders provide insights that can be applied to Unspecified Sleep-Wake Disorder.

One area of research focuses on the impact of sleep disorders on mental health. A study by Baglioni et al. (2011) explored the relationship between sleep disorders and depression, demonstrating a bidirectional link. This study found that sleep disturbances, such as those seen in Unspecified Sleep-Wake Disorder, can be both a precursor and a consequence of depression. This research implies that addressing sleep issues might play a role in mitigating depressive symptoms.

Another significant area of research is the impact of sleep disorders on physical health. Medic et al. (2017) conducted a review that highlighted the association between various sleep disorders and increased risks of obesity, diabetes, and cardiovascular diseases. This research suggests that the disruptions in sleep patterns characteristic of Unspecified Sleep-Wake Disorder could contribute to these physical health problems.

Cognitive-behavioral therapy for insomnia (CBT-I) has been extensively researched as a treatment for various sleep disorders. A study by Manber et al. (2016) evaluated the efficacy of CBT-I in treating insomnia, a common component of many sleep disorders, including Unspecified Sleep-Wake Disorder. The study concluded that CBT-I is an effective treatment for insomnia, with improvements in sleep quality and duration.

Regarding pharmacological interventions, research focuses more on specific sleep disorders than the broad category of Unspecified Sleep-Wake Disorder. However, studies like those conducted by Krystal (2012) have evaluated the effectiveness of various sleep medications across different sleep disorders, providing insights that also apply to Unspecified Sleep-Wake Disorder.

It is important to note that while these studies provide valuable insights, applying their findings to Unspecified Sleep-Wake Disorder should be approached cautiously due to the disorder's broad and varied nature.

Treatment and Interventions

The treatment and intervention strategies for Unspecified Sleep-Wake Disorder, while not specifically outlined in the research due to the broad and encompassing nature of the disorder, can be inferred from the approaches used for various other sleep disorders. These strategies often involve a combination of behavioral, psychological, and pharmacological interventions.

Cognitive-Behavioral Therapy for Insomnia (CBT-I) is a widely researched and effective non-pharmacological treatment approach for insomnia, which is a common component of many sleep disorders. A study by Manber et al. (2016) demonstrated that CBT-I, which includes techniques such as sleep restriction, stimulus control, cognitive restructuring, and relaxation training, effectively improves sleep quality and duration in individuals with insomnia. This approach could be beneficial for patients with Unspecified Sleep-Wake Disorder who exhibit insomnia-like symptoms.

Pharmacological treatments, such as the use of sedative-hypnotics, are also common in managing sleep disorders. Krystal (2012) researched the efficacy of these medications across various sleep disorders, suggesting their potential usefulness in treating sleep disturbances. However, the study also emphasized the importance of careful consideration of the risks and benefits of these medications, as well as their potential for dependence and tolerance.

Melatonin supplementation has been explored as a treatment for circadian rhythm disruptions, which may be a component of Unspecified Sleep-Wake Disorder. A review by Srinivasan et al. (2010) highlighted the role of melatonin in regulating sleep-wake cycles and its effectiveness in treating circadian rhythm sleep disorders. This treatment could apply to patients with Unspecified Sleep-Wake Disorder who have symptoms related to circadian rhythm disturbances.

Additionally, lifestyle modifications and sleep hygiene practices are fundamental components of treatment for sleep disorders. A study by Irish et al. (2015) emphasized the importance of maintaining a regular sleep-wake schedule, creating a conducive sleep environment, and moderating the intake of caffeine and alcohol to improve sleep quality. These interventions are generally recommended for all individuals with sleep disturbances, including those with Unspecified Sleep-Wake Disorder.

It is important to note that the treatment of Unspecified Sleep-Wake Disorder should be individualized based on the specific symptoms and needs of the patient. A comprehensive assessment is crucial to determine the most appropriate intervention strategies.

Implications if Untreated

Untreated Unspecified Sleep-Wake Disorder, like other untreated sleep disorders, can have far-reaching implications for an individual's health and well-being. The research literature on sleep disorders broadly addresses these concerns, providing insights applicable to Unspecified Sleep-Wake Disorder.

Chronic sleep deprivation and poor sleep quality have been linked to various physical health issues. A study by Medic et al. (2017) reviewed the short- and long-term health consequences of sleep disruption, finding significant associations with obesity, diabetes, cardiovascular diseases, and reduced immune function. These findings underscore the potential physical health risks associated with ongoing sleep disturbances, such as those seen in Unspecified Sleep-Wake Disorder.

Mental health can also be adversely affected by untreated sleep disorders. Baglioni et al. (2011) conducted a meta-analysis examining the relationship between insomnia and depression, demonstrating that chronic sleep disturbances are a significant risk factor for the development of depressive disorders. This suggests that untreated Unspecified Sleep-Wake Disorder, which may involve insomnia-like symptoms, could increase the risk of developing or exacerbating mental health issues.

Cognitive functioning is another area impacted by poor sleep. Lim and Dinges (2010) explored the cognitive consequences of sleep deprivation, finding impairments in attention, working memory, decision-making, and risk assessment. This research highlights the potential for untreated sleep disturbances to impact cognitive abilities and daily functioning negatively.

Moreover, sleep disorders can affect the quality of life and social functioning. A study by Kyle et al. (2010) investigated the impact of chronic insomnia on quality of life, revealing significant impairments in daytime functioning, work productivity, social relationships, and overall quality of life. These findings can be extrapolated to Unspecified Sleep-Wake Disorder, indicating potential social and occupational implications if the disorder remains untreated.

In summary, untreated Unspecified Sleep-Wake Disorder can lead to a range of adverse outcomes, affecting physical health, mental health, cognitive functioning, and overall quality of life. These findings underscore the importance of diagnosing and treating sleep disturbances promptly and effectively.

Summary

Unspecified Sleep-Wake Disorder, as classified in the DSM-5-TR, presents significant challenges in diagnosis and treatment due to its inherently broad and non-specific nature. This disorder represents a category for sleep disturbances that do not conform to the detailed criteria of other, more defined sleep disorders. Historically, the evolution of the DSM's approach to sleep disorders reflects a growing recognition of the complexity of sleep-related issues and an increased understanding of their multifaceted nature. This evolution has led to more inclusive and compassionate perspectives on sleep disorders, recognizing the wide range of symptoms and causes that may not fit neatly into defined categories.

Diagnosing Unspecified Sleep-Wake Disorder is particularly challenging as it often requires a process of elimination and careful consideration of a broad spectrum of symptoms. The challenge lies in accurately characterizing and treating the sleep disturbance when it does not align with specific, well-defined disorders. This diagnostic complexity underscores the importance of a comprehensive and individualized approach to assessment and treatment.

The impact of Unspecified Sleep-Wake Disorder on an individual's life can be profound. Research has shown chronic sleep disturbances can disrupt personal identity, relationships, and daily functioning. A study by Morin et al. (2006) highlighted the negative impact of chronic insomnia on interpersonal relationships, mood, and daytime functioning, emphasizing that these issues can lead to a diminished sense of self and reduced quality of life. Similarly, the work of Kyle et al. (2010) reinforced the notion that sleep disorders can significantly impair social and occupational functioning, further affecting one's sense of identity and confidence.

Furthermore, the disorder can have a cascading effect on the individual’s ability to perform daily activities, maintain relationships, and manage professional responsibilities, as indicated by the research of Baglioni et al. (2011). The disruption of these fundamental aspects of life can lead to a vicious cycle of stress and anxiety, which may exacerbate the sleep disorder itself.

In conclusion, Unspecified Sleep-Wake Disorder poses unique challenges in the realms of diagnosis and treatment. Its impact on an individual's identity, relationships, and overall quality of life underscores the necessity for a nuanced, patient-centric approach in clinical assessment and intervention. The evolution of perspectives on this disorder reflects a broader shift towards recognizing the complex, individual nature of sleep disturbances and the importance of addressing them with empathy and thoroughness.

References

Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2014). Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders, 135(1-3), 10-19.

Baglioni, C., Spiegelhalder, K., Lombardo, C., & Riemann, D. (2011). Sleep and emotions: A focus on insomnia. Sleep Medicine Reviews, 15(4), 227-238.

Barclay, N. L., & Gregory, A. M. (2013). Quantitative genetic research on sleep: A review of normal sleep, sleep disturbances and associated emotional, behavioural, and health-related difficulties. Sleep Medicine Reviews, 17(1), 29–40.

Besedovsky, L., Lange, T., & Born, J. (2012). Sleep and immune function. Pflügers Archiv - European Journal of Physiology, 463(1), 121-137.

Chang, A. M., Aeschbach, D., Duffy, J. F., & Czeisler, C. A. (2015). Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. Proceedings of the National Academy of Sciences, 112(4), 1232-1237.

Foley, D. J., Monjan, A. A., Brown, S. L., Simonsick, E. M., Wallace, R. B., & Blazer, D. G. (1999). Sleep complaints among elderly persons: An epidemiologic study of three communities. Sleep, 22(4), 425–433.

Ford, D. E., & Kamerow, D. B. (1989). Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA, 262(11), 1479-1484.

Irish, L. A., Kline, C. E., Gunn, H. E., Buysse, D. J., & Hall, M. H. (2015). The role of sleep hygiene in promoting public health: A review of empirical evidence. Sleep Medicine Reviews, pp. 22, 23–36.

Knutson, K. L., Van Cauter, E., Rathouz, P. J., DeLeire, T., & Lauderdale, D. S. (2007). Trends in the prevalence of short sleepers in the USA: 1975–2006. Sleep, 33(1), 37-45.

Krakow, B., & Zadra, A. (2006). Clinical management of chronic nightmares: Imagery rehearsal therapy. Behavioral Sleep Medicine, 4(1), 45-70.

Krystal, A. D. (2012). The changing perspective on chronic insomnia management. Journal of Clinical Psychiatry, 73(8), e29.

Kyle, S. D., Morgan, K., & Espie, C. A. (2010). Insomnia and health-related quality of life. Sleep Medicine Reviews, 14(1), 69–82.

Lim, J., & Dinges, D. F. (2010). A meta-analysis of the impact of short-term sleep deprivation on cognitive variables. Psychological Bulletin, 136(3), 375-389.

Manber, R., Carney, C., Edinger, J., Epstein, D., Friedman, L., Haynes, P. L., Karlin, B. E., Pigeon, W., Siebern, A. T., & Trockel, M. (2016). Dissemination of CBTI to the non-sleep specialist: Protocol development and training issues. Journal of Clinical Sleep Medicine, 12(3), 343-352.

Medic, G., Wille, M., & Hemels, M. E. H. (2017). Short- and long-term health consequences of sleep disruption. Nature and Science of Sleep, 9, 151-161.

Morin, C. M., LeBlanc, M., Daley, M., Gregoire, J. P., & Mérette, C. (2006). Epidemiology of insomnia: Prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Medicine, 7(2), 123-130.

Ohayon, M. M., & Roth, T. (2003). Place of chronic insomnia in the course of depressive and anxiety disorders. Journal of Psychiatric Research, 37(1), 9-15.

Roth, T. (2007). Insomnia: Definition, prevalence, etiology, and consequences. Journal of Clinical Sleep Medicine, 3(5 Suppl), S7-S10.

Smith, M. T., & Haythornthwaite, J. A. (2004). How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Medicine Reviews, 8(2), 119–132.

Somers, V. K., White, D. P., Amin, R., Abraham, W. T., Costa, F., Culebras, A., Daniels, S., Floras, J. S., Hunt, C. E., Olson, L. J., Pickering, T. G., Russell, R., Woo, M., & Young, T. (2008). Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement. Journal of the American College of Cardiology, 52(8), 686–717.

Srinivasan, V., Pandi-Perumal, S. R., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2010). Melatonin in Alzheimer's disease and other neurodegenerative disorders. Behavioral and Brain Functions, 6, 13.

Tasali, E., Leproult, R., & Spiegel, K. (2008). Reduced sleep duration or quality: Relationships with insulin resistance and type 2 diabetes. Progress in Cardiovascular Diseases, 51(5), 381-391.

Taylor, D. J., Lichstein, K. L., & Durrence, H. H. (2005). Insomnia as a health risk factor. Behavioral Sleep Medicine, 1(4), 227-247.

Watson, N. F., Badr, M. S., Belenky, G., Bliwise, D. L., Buxton, O. M., Buysse, D., Dinges, D. F., Gangwisch, J., Grandner, M. A., Kushida, C., Malhotra, R. K., Martin, J. L., Patel, S. R., Quan, S. F., & Tasali, E. (2017). Joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society on the recommended amount of sleep for a healthy adult: Methodology and discussion. Journal of Clinical Sleep Medicine, 13(8), 1041-1054.

Zhang, B., & Wing, Y. K. (2006). Sex differences in insomnia: A meta-analysis. Sleep, 29(1), 85–93.